APA (7th ed.) Citation

Tetsuo Nakayama, Masahiro Eda, Motonori Hirano, & Wakako Goto. (2019). Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: A randomized phase I/II clinical trial. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Tetsuo Nakayama, Masahiro Eda, Motonori Hirano, and Wakako Goto. Immunogenicity and Safety of the New MMR Vaccine Containing Measles AIK-C, Rubella Takahashi, and Mumps RIT4385 Strains in Japanese Children: A Randomized Phase I/II Clinical Trial. Taylor & Francis Group, 2019.

MLA (9th ed.) Citation

Tetsuo Nakayama, et al. Immunogenicity and Safety of the New MMR Vaccine Containing Measles AIK-C, Rubella Takahashi, and Mumps RIT4385 Strains in Japanese Children: A Randomized Phase I/II Clinical Trial. Taylor & Francis Group, 2019.